| |
| Device | EUFLEXXA (1% SODIUM HYALURONATE) |
| Generic Name | Acid, hyaluronic, intraarticular |
| Applicant | Ferring Pharmaceuticals, Inc. 100 Interpace Pkwy. Parsippany, NJ 07054 |
| PMA Number | P010029 |
| Date Received | 05/01/2001 |
| Decision Date | 12/03/2004 |
| Product Code |
MOZ |
| Docket Number | 06M-0338 |
| Notice Date | 08/24/2006 |
| Advisory Committee |
Orthopedic |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement APPROVAL FOR NUFLEXXA (1% SODIUM HYALURONATE). THE DEVICE IS INDICATED FOR THE TREATMENT OF PAIN IN OSTEOARTHRITIS (OA) OF THE KNEE IN PATIENTS WHO HAVE FAILED TO RESPOND ADEQUATELY TO CONSERVATIVE NON-PHARMACOLOGIC THERAPY AND TO SIMPLE ANALGESICS (E.G., ACETAMINOPHEN). |
| Approval Order | Approval Order |
| Summary | Summary of Safety and Effectiveness |
| Labeling | Labeling Labeling Part 2 |
| Supplements: |
S021 S020 S001 S007 S002 S004 S025 S012 S014 S015 S016 S017 S022 S023 S019 S018 S013 S024 S006 S009 S008 S010 S011 S029 S032 S033 S035 S041 S026 S027 S030 S028 S036 S034 S037 S038 S042 S039 S040 S043 |